1. Home
  2. ARRY vs AVBP Comparison

ARRY vs AVBP Comparison

Compare ARRY & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARRY
  • AVBP
  • Stock Information
  • Founded
  • ARRY 1989
  • AVBP 2021
  • Country
  • ARRY United States
  • AVBP United States
  • Employees
  • ARRY N/A
  • AVBP N/A
  • Industry
  • ARRY Semiconductors
  • AVBP
  • Sector
  • ARRY Technology
  • AVBP
  • Exchange
  • ARRY Nasdaq
  • AVBP NYSE
  • Market Cap
  • ARRY 1.0B
  • AVBP 948.5M
  • IPO Year
  • ARRY 2020
  • AVBP 2024
  • Fundamental
  • Price
  • ARRY $5.86
  • AVBP $27.15
  • Analyst Decision
  • ARRY Buy
  • AVBP Strong Buy
  • Analyst Count
  • ARRY 22
  • AVBP 5
  • Target Price
  • ARRY $12.61
  • AVBP $36.80
  • AVG Volume (30 Days)
  • ARRY 5.5M
  • AVBP 140.0K
  • Earning Date
  • ARRY 11-07-2024
  • AVBP 02-02-2025
  • Dividend Yield
  • ARRY N/A
  • AVBP N/A
  • EPS Growth
  • ARRY N/A
  • AVBP N/A
  • EPS
  • ARRY N/A
  • AVBP N/A
  • Revenue
  • ARRY $982,190,000.00
  • AVBP N/A
  • Revenue This Year
  • ARRY N/A
  • AVBP N/A
  • Revenue Next Year
  • ARRY $23.78
  • AVBP N/A
  • P/E Ratio
  • ARRY N/A
  • AVBP N/A
  • Revenue Growth
  • ARRY N/A
  • AVBP N/A
  • 52 Week Low
  • ARRY $5.15
  • AVBP $14.35
  • 52 Week High
  • ARRY $18.92
  • AVBP $36.37
  • Technical
  • Relative Strength Index (RSI)
  • ARRY 44.50
  • AVBP 44.58
  • Support Level
  • ARRY $5.15
  • AVBP $25.36
  • Resistance Level
  • ARRY $6.19
  • AVBP $27.66
  • Average True Range (ATR)
  • ARRY 0.38
  • AVBP 1.23
  • MACD
  • ARRY -0.07
  • AVBP -0.16
  • Stochastic Oscillator
  • ARRY 28.88
  • AVBP 37.56

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Its operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

Share on Social Networks: